Enhance MD vs Live Vital
Enhance's longest Core label bills every 48 weeks with four-week delivery; Live Vital advertises a ten-week protocol. Neither label alone settles the next charge.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Enhance MD
Partner
$230/mo
Core's $212 rate covers four weeks under the longest plan, billed every 48 weeks. The $169 tirzepatide headline is a separate 1 mg weekly microdose with 12-week delivery. Compare the billing commitment as well as the advertised monthly rate.
- Three pharmacy partners named in the terms with contact details
- Core and Advanced print billing intervals beside their rates
- The microdosing tier publishes a 1 mg weekly strength
- Core lists six-month labs, essential supplies and free shipping
- Core and Advanced use four-week delivery; their twelve-month label bills every forty-eight weeks
- No publicly priced one-month drug tier appears for microdosing
- Core and Advanced publish no milligram strength at any dose
- Eligibility is decided after payment, with a refund if declined
Pick it for: Comparing a longer term with four-week delivery
Not for: Anyone seeking the longest-plan rate without a longer billing commitment.
Live Vital
Partner
$130/mo
The ten-week protocol total is more useful than the monthly headline. Both GLP-1 pages explicitly describe compounded injections. Confirm the prescribed supply, dispensing pharmacy and next charge; the protocol label does not establish that billing stops.
- The protocol total is published beside the rate
- The advertised protocol length is stated
- Product pages identify weekly injections
- The site describes physician review
- A ten-week protocol is priced as three months
- Renewal arrangements need clarification before purchase
- The refund policy contains unfinished policy text
- Compounding pharmacy is not named
Pick it for: Considering a ten-week label after confirming renewal and pharmacy
Not for: Anyone comparing advertised monthly figures at face value.
Our verdict
Enhance's longest Core rate uses a 48-week billing period, while medication arrives every four weeks. Its terms say subscriptions renew unless canceled before the next billing cycle. Live Vital explicitly describes compounded semaglutide and labels its offer as a ten-week protocol, but its reviewed policies do not establish automatic renewal or non-renewal for that product. Confirm the total due, prescribed supply and next billing date before comparing the two. Live Vital's FAQ describes a licensed 503A pharmacy without identifying the dispenser; Enhance publishes differing pharmacy lists, so confirm the assignment with either care team.
What actually separates them
Enhance MD and Live Vital differ on published price and names its pharmacy. The table summarizes those terms; confirm any details it does not cover with the provider.
Enhance MD’s comparison figure is $100 higher than Live Vital’s — a 77% difference between the listed rates. These figures do not establish equivalent prescribed doses, supply or care. Confirm the selected product, full payment obligation and next charge.
At unchanged rates, a twelve-month illustration is about $1,560 at Live Vital against $2,760 at Enhance MD — a difference of $1,200. This is not a quote for a year of care: actual charges depend on prescribed supply, purchase terms and renewals.
| Enhance MD | Live Vital | |
|---|---|---|
| Published price | $230/mo | $130/mo |
| Names its pharmacy | Yes | No |
Before you choose either
The providers describe different service areas. Enhance MD lists 1 state that Live Vital does not list — DC. Live Vital lists 10 that Enhance MD does not list — AL, AR, GA, HI, LA, MO, MS, ND, SC, TN. Confirm your location and selected medication directly. A provider-wide footprint does not establish every treatment’s availability.
Whether these two publish a milligram dose is not settled in our records for both of them, so treat the two prices as not yet comparable and ask each what dose the monthly figure buys. Set the answers against every published price we hold — a lower monthly price at a smaller dose is not the cheaper option.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.